NCT07379125 2026-01-30
Therapeutic RSK1 Targeting in Myelofibrosis
Washington University School of Medicine
Phase 1 Not yet recruiting
Clinical Trials
16 trialsNCT04217356 2026-01-26
ALLO-BAT
University Health Network, Toronto
Active not recruiting
NCT07362225 2026-01-23
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
MPN Research Foundation
Recruiting
NCT05690230 2025-04-24
Improving Patient Experience: BMBA
Thomas Jefferson University
Phase NA Completed
NCT03640325 2024-10-26
The PRISM Intervention for Adolescents and Young Adults Receiving Hematopoietic Cell Transplantation
Seattle Children's Hospital
Phase NA Completed
NCT03859427 2024-08-13
ARROW2
Amgen
Phase 3 Completed
NCT05632874 2022-12-01
The Effect of Relaxing Breathing Exercise Applied to Patients Before Bone Marrow Biopsy on Vital Signs, Pain and Anxiety Levels
Uskudar University
Phase NA Unknown
NCT05488717 2022-08-08
The Effect of Art-Based Mandala on Mental Health in Bone Marrow Transplant Patients
Istanbul University
Phase NA Completed
NCT04709458 2022-05-03
Safety and Early Efficacy Study of TBX-2400 in Patients With AML or Myelofibrosis
Taiga Biotechnologies, Inc.
Phase 1 Unknown
NCT05251168 2022-02-23
PET Guided Bone Marrow Biopsy vs Trephine Bone Marrow Biopsy
Post Graduate Institute of Medical Education and Research, Chandigarh
Completed
NCT01286077 2016-05-30
Velcade Consolidation Bone Study
Janssen-Cilag International NV
Phase 2 Completed
NCT00431340 2015-07-08
A Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple Myeloma
Valerio Therapeutics
Phase 2 Terminated
NCT00908232 2015-01-15
SEQUENTIAL
Janssen-Cilag International NV
Phase 2 Completed
NCT02020928 2013-12-25
lasertherapy
Instituto Materno Infantil Prof. Fernando Figueira
Phase 3 Unknown
NCT00113893 2013-11-07
SCIO-469: Open-Label Study for Patients With Myelodysplastic Syndromes.
Scios, Inc.
Phase 2 Completed
NCT00421213 2012-07-19
Phase II Study of ZIO-101 in Advanced Blood and Bone Marrow Cancers
Alaunos Therapeutics
Phase 2 Completed